A carregar...

Profile of eliglustat tartrate in the management of Gaucher disease

Gaucher disease (GD) is a lysosomal storage disorder caused by the deficient activity of acid beta glucosidase, with consequent accumulation of glucosylceramide in the spleen, liver, bone marrow, and various organs and tissues. Currently, the gold standard for GD treatment is enzyme replacement ther...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Clin Risk Manag
Main Authors: Sechi, Annalisa, Dardis, Andrea, Bembi, Bruno
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4714736/
https://ncbi.nlm.nih.gov/pubmed/26811686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S73226
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!